UNSPSC 51372801: Ketazocine

This classification denotes an opioid receptor agonist with the molecular formula C18H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6IO4IG518S, chemically known as 2,6-methano-3-benzazocin-1(2h)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11s*)- but generally known as ketazocine, which bears US NIH Compound Identifier 71426. European Medicines Agency schedules Ketazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08367MIG.

UNSPSC 51372801 Ketazocine is a Commodity code with minimal recent state and local procurement activity. The one supported recent opportunity shows the code being applied to naloxone and drug deactivation systems procurements, which fall outside ketazocine's scope; state and local governments are not currently soliciting ketazocine itself under this code.

Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with an optional one-year renewal, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify, and insurance coverage. This appears to be a mislabeling of the opportunity within the UNSPSC taxonomy rather than authentic demand for ketazocine; the code shows no relevant recent activity for the opioid antagonist product it nominally represents.